{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:15:35Z","timestamp":1760141735049,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lipodystrophy syndromes (LS) are characterized by reduced body fat and associated metabolic complications, such as insulin resistance and diabetes. The diagnosis of LS can be challenging in clinical settings. Skinfold measurement and body composition assessment using DEXA are commonly used for screening and diagnosis. This study aimed to identify alternative easy-to-use body composition parameters for diagnosing LS in clinical settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This cross-sectional study included patients with genetically confirmed congenital generalized lipodystrophy (CGL) and familial partial lipodystrophy (FPL), with 62 matched healthy controls. Comprehensive data, including medical history, body composition, laboratory measurements, and imaging parameters, were collected. The receiver operating characteristic (ROC) curve was constructed using genetic test results, the gold standard for diagnosing genetic lipodystrophy, as the reference, and the sensitivity and specificity of calf skinfold measurements were measured with those of the genetic tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We included 62 patients with a mean age of 32\u2009\u00b1\u200918 (2\u201368) years, of whom 69.3% were women. The prevalence of diabetes mellitus (70%) and hypertriglyceridemia (83%) were also high. All body composition parameters significantly differed, except for calf skinfold measurements, which were similar between the CGL and FPL patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.270). The ROC curve analysis identified a new cutoff point for calf skinfold measurement of &lt;8\u00a0mm, with high diagnostic accuracy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study identified calf skinfold measurements &lt;8\u00a0mm as an accurate diagnostic tool for CGL and FPL. Notably, clinical accessibility to calf skinfold will favor its widespread use, standardization, and inclusion in physical examination protocols, improving lipodystrophy detection and diagnosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13098-025-01934-y","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:44:25Z","timestamp":1760071465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calf skinfold measurements as a diagnostic tool for lipodystrophy syndromes: a cross-sectional study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-4269","authenticated-orcid":false,"given":"Grayce Ellen","family":"da Cruz Paiva Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-858X","authenticated-orcid":false,"given":"Fabia Karine","family":"de Moura Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5418-022X","authenticated-orcid":false,"given":"Jessica Silveira","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-3574","authenticated-orcid":false,"given":"Nat\u00e1lia Prado","family":"Boris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-6551","authenticated-orcid":false,"given":"Virginia Oliveira","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-3737","authenticated-orcid":false,"given":"Victor Rezende","family":"Veras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-7227","authenticated-orcid":false,"given":"Mayara Teixeira Alexandrino","family":"Sales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-5499","authenticated-orcid":false,"given":"Lorena Ta\u00fasz Tavares","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-0126","authenticated-orcid":false,"given":"Amanda Caboclo","family":"Flor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8353-2912","authenticated-orcid":false,"given":"Ana Paula Dias Rangel","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-5612","authenticated-orcid":false,"given":"Maria Helane Gurgel","family":"Castelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-8521","authenticated-orcid":false,"given":"Clarisse Mourao Melo","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5295-2480","authenticated-orcid":false,"given":"J\u00falia Lemos Lima","family":"Verde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-1125","authenticated-orcid":false,"given":"Maria C.","family":"Foss-Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-8726","authenticated-orcid":false,"given":"Renan Magalh\u00e3es","family":"Montenegro Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"11","key":"1934_CR1","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1210\/jc.2018-02730","volume":"104","author":"B Akinci","year":"2019","unstructured":"Akinci B, Oral EA, Neidert A, Rus D, Cheng WY, Thompson-Leduc P, et al. Comorbidities and survival in patients with lipodystrophy: an international chart review study. J Clin Endocrinol Metab. 2019;104(11):5120\u201335.","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"1934_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189724","volume":"18","author":"EBL Freire","year":"2021","unstructured":"Freire EBL, d\u2019Alva CB, Madeira MP, Lima GEdaCP, Montenegro APDR, Fernandes VO, et al. Bone mineral density in congenital generalized lipodystrophy: the role of bone marrow tissue, adipokines, and insulin resistance. Int J Environ Res Public Health. 2021;18(18):9724.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1934_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13098-022-00908-8","volume":"14","author":"RM Montenegro Junior","year":"2022","unstructured":"Montenegro Junior RM, Ponte CMM, Castelo MHCG, de Oliveira Silveira AC, Fernandes VO, D\u2019Alva CB, et al. Reduced gut microbiota diversity in patients with congenital generalized lipodystrophy. Diabetol Metab Syndr. 2022;14(1):136.","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"1934_CR4","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, et al. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016;101(12):4500\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1934_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2015.123","volume":"11","author":"N Patni","year":"2015","unstructured":"Patni N, Garg A. Congenital generalized lipodystrophies - new insights into metabolic dysfunction. Nat Rev Endocrinol. 2015;11(9):522\u201334.","journal-title":"Nat Rev Endocrinol"},{"key":"1934_CR6","first-page":"1","volume":"19","author":"J Capeau","year":"2010","unstructured":"Capeau J, Magr\u00e9 J, Caron-Debarle M, Lagathu C, Antoine B, Lascols O, et al. Human lipodystrophies: genetic and acquired diseases of adipose tissue in: adipose tissue development. Karger Publ. 2010;19:1\u201320.","journal-title":"Karger Publ"},{"issue":"2","key":"1934_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17446651.2020.1735360","volume":"15","author":"MC Foss-Freitas","year":"2020","unstructured":"Foss-Freitas MC, Akinci B, Luo Y, Stratton A, Oral EA. Diagnostic strategies and clinical management of lipodystrophy. Expert Rev Endocrinol Metab. 2020;15(2):95\u2013114.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"1934_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12020-018-1589-1","volume":"60","author":"RJ Brown","year":"2018","unstructured":"Brown RJ, Oral EA, Cochran E, Ara\u00fajo-Vilar D, Savage DB, Long A, et al. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine. 2018;60(3):479\u201389.","journal-title":"Endocrine"},{"issue":"7","key":"1934_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/dom.12606","volume":"18","author":"C Vatier","year":"2016","unstructured":"Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline JP, et al. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes. Diabetes Obes Metab. 2016;18(7):693\u20137.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"1934_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/00913847.1985.11708790","volume":"13","author":"AS Jackson","year":"1985","unstructured":"Jackson AS, Pollock ML. Practical assessment of body composition. Phys Sportsmed. 1985;13(5):76\u201390.","journal-title":"Phys Sportsmed"},{"key":"1934_CR11","unstructured":"Harrison GG. Skinfold thickness and measurement technique. Anthr Stand Ref Man. 1988; 55\u201370."},{"issue":"72","key":"1934_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.diabres.2005.10.017","volume":"2","author":"B Geloneze","year":"2006","unstructured":"Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population. Diabetes Res Clin Pract. 2006;2(72):219\u201320.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1934_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1590\/S0004-27302009000200020","volume":"53","author":"B Geloneze","year":"2009","unstructured":"Geloneze B, Vasques ACJ, Stabe CFC, Pareja JC, de Rosado LEFP, de Queiroz EC, et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: brazilian metabolic syndrome study (BRAMS). Arq Bras Endocrinol Metabol. 2009;53(2):281\u20137.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1934_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.803189","volume":"12","author":"J Zammouri","year":"2021","unstructured":"Zammouri J, Vatier C, Capel E, Auclair M, Storey-London C, Bismuth E, et al. Molecular and cellular bases of lipodystrophy syndromes. Front Endocrinol. 2021;12:803189.","journal-title":"Front Endocrinol"},{"key":"1934_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.123","author":"N Patni","year":"2015","unstructured":"Patni N, Garg A. Congenital generalized lipodystrophies \u2014 new insights into metabolic dysfunction. Nat Rev Endocrinol. 2015. https:\/\/doi.org\/10.1038\/nrendo.2015.123.","journal-title":"Nat Rev Endocrinol"},{"key":"1934_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","volume":"7","author":"AK Agarwal","year":"2006","unstructured":"Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genomics Hum Genet. 2006;7:175\u201399.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1934_CR17","first-page":"552022","volume":"10","author":"R Cobas","year":"2022","unstructured":"Cobas R, Rodacki M, Giacaglia L, Calliari LEP, Noronha RM, Valerio C, et al. Diagn\u00f3stico do diabetes e rastreamento do diabetes tipo 2. Dir DA Soc Bras Diabetes. 2022;10:552022\u20137753.","journal-title":"Dir DA Soc Bras Diabetes"},{"issue":"1","key":"1934_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","volume":"19","author":"Y Handelsman","year":"2013","unstructured":"Handelsman Y, Oral E, Bloomgarden Z, Brown R, Chan J, Einhorn D, et al. The clinical approach to the detection of lipodystrophy\u2013an AACE consensus statement. Endocr Pract. 2013;19(1):107\u201316.","journal-title":"Endocr Pract"},{"key":"1934_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","volume":"54","author":"C Guill\u00edn-Amarelle","year":"2016","unstructured":"Guill\u00edn-Amarelle C, S\u00e1nchez-Iglesias S, Castro-Pais A, Rodriguez-Ca\u00f1ete L, Ord\u00f3\u00f1ez-May\u00e1n L, Pazos M, et al. Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome. Endocrine. 2016;54:411\u201321.","journal-title":"Endocrine"},{"key":"1934_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-4-40","volume":"4","author":"CM Valerio","year":"2012","unstructured":"Valerio CM, Zajdenverg L, de Oliveira JEP, Mory PB, Moyses R, Godoy-Matos AF. Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012;4:1\u20136.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"1934_CR21","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1210\/clinem\/dgaa137","volume":"105","author":"C Vasandani","year":"2020","unstructured":"Vasandani C, Li X, Sekizkardes H, Adams-Huet B, Brown RJ, Garg A. Diagnostic value of anthropometric measurements for familial partial lipodystrophy, Dunnigan variety. J Clin Endocrinol Metab. 2020;105(7):2132\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1934_CR22","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2337\/dc18-0978","volume":"41","author":"R Meral","year":"2018","unstructured":"Meral R, Ryan BJ, Malandrino N, Jalal A, Neidert AH, Muniyappa R, et al. \u201cFat shadows\u201d from DXA for the qualitative assessment of lipodystrophy: when a picture is worth a thousand numbers. Diabetes Care. 2018;41(10):2255\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"1934_CR23","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41598-023-27987-5","volume":"13","author":"NB da Cunha Olegario","year":"2023","unstructured":"da Cunha Olegario NB, da Cunha Neto JS, Barbosa PCS, Pinheiro PR, Landim PLA, Montenegro APDR, et al. Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO. Sci Rep. 2023;13(1):2176.","journal-title":"Sci Rep"},{"issue":"2","key":"1934_CR24","first-page":"111","volume":"29","author":"J K\u00f6bberling","year":"1975","unstructured":"K\u00f6bberling J, Willms B, Kattermann R, Creutzfeldt W. Lipodystrophy of the extremities a dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik. 1975;29(2):111\u201320.","journal-title":"Humangenetik"},{"issue":"1","key":"1934_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13098-024-01413-w","volume":"16","author":"VR Veras","year":"2024","unstructured":"Veras VR, da Cruz Paiva Lima GE, da Ponte Melo I, Fernandes VO, de Moura Lopes FK, do Amaral CL, et al. Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women. Diabetol Metab Syndr. 2024;16(1):216.","journal-title":"Diabetol Metab Syndr"},{"key":"1934_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fendo.2018.00458","volume":"9","author":"RM Montenegro Jr","year":"2018","unstructured":"Montenegro RM Jr, Costa-Riquetto AD, Fernandes VO, Montenegro APDR, de Santana LS, de Jorge AA, et al. Homozygous and heterozygous nuclear lamin A p. R582C mutation different lipodystrophic phenotypes in the same kindred. Front Endocrinol. 2018;9:458.","journal-title":"Front Endocrinol"},{"key":"1934_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2024.05.013","volume-title":"Effects of glucocorticoids on adipose tissue plasticity","author":"A Vali","year":"2024","unstructured":"Vali A, Beaup\u00e8re C, Loubaresse A, Dalle H, F\u00e8ve B, Grosfeld A, et al. Effects of glucocorticoids on adipose tissue plasticity. Amsterdam: Elsevier; 2024."},{"issue":"10","key":"1934_CR28","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1172\/JCI129190","volume":"129","author":"JP Mann","year":"2019","unstructured":"Mann JP, Savage DB. What lipodystrophies teach us about the metabolic syndrome. J Clin Invest. 2019;129(10):4009\u201321.","journal-title":"J Clin Invest"},{"issue":"9","key":"1934_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11892-022-01485-w","volume":"22","author":"N Patni","year":"2022","unstructured":"Patni N, Garg A. Lipodystrophy for the diabetologist\u2014what to look for. Curr Diab Rep. 2022;22(9):461\u201370.","journal-title":"Curr Diab Rep"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:44:28Z","timestamp":1760071468000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01934-y","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by Ethics Committee of the Federal University of Cear\u00e1 (CAAE 41766820.2.0000.5045 and 56365822.6.0000.5045).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}